Mental and behavioural disorders due to psychoctive substance use

F5_SUBSTANCE

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

22368

diagram downward connector
F5_SUBSTANCE

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 22368 7867 14501
Unadjusted prevalence (%) 6.29 3.97 9.21
Mean age at first event (years) 45.08 41.40 47.08

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.08 5.38 [4.63, 6.24] <1e-100 4147
15 years 0.02 3.10 [2.76, 3.48] 1.6e-81 1599
5 years 0.01 5.30 [4.79, 5.87] <1e-100 958
1 year 0.00 23.40 [20.76, 26.37] <1e-100 873

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: F5_SUBSTANCE – Mental and behavioural disorders due to psychoctive substance use
GWS hits:

Survival analyses between endpoints

Plot

before Mental and behavioural disorders due to psychoctive substance use
after Mental and behavioural disorders due to psychoctive substance use

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Mental and behavioural disorders due to psychoctive substance use